Chiroptical Spectroscopic Studies on Lanthanide Complexes with Valinamide Derivatives in Solution.

Ligands based on 2,2'-bipyridine and valinamide moieties induce circularly polarized luminescence in their europium complexes. Both the R and S enantiomers of the complexes were successfully obtained. Single-crystal X-ray analysis of the racemic crystal confirmed that the ligand is coordinated to the europium ion in a tetradentate fashion. The π-electronic system of the ligand is co-planar with the valinamide moiety, and acts as an efficient photoantenna to sensitize europium luminescence by UV excitation. The luminescence quantum yield (QY) of europium in the valinamide-containing complex was 44 % in acetonitrile. The glum value to evaluate the circularly polarized luminescence was relatively high at |0.13| estimated from their magnetic dipole transitions around 593 nm. For comparison, we prepared hexadentate europium complexes in the S- and R-forms derived from two bipyridine moieties linked by ethylenediamines. The determined QYs were 18 % (S) and 16 % (R), and the glum value |0.12| for the hexadentate complexes. The photophysical properties of the gadolinium complexes of the ligands were also evaluated.

Cytotoxic activities of amino acid-conjugate derivatives of abietane-type diterpenoids against human cancer cell lines.

Nine amino acid conjugate derivatives, each 2-10 and 12-20, were prepared from abietic acid (1) and dehydroabietic acid (11), respectively, and they were evaluated for their cytotoxicities against four human cancer cell lines, i.e., leukemia (HL60), lung (A549), stomach (AZ521), and breast (SK-BR-3). All compounds showed cytotoxicities against HL60 with IC50 values in the range of 2.3-37.3 µM. In addition, most of the derivatives exhibited moderate cytotoxicities against the other cancer cell lines. Among the derivatives, methyl N-[18-oxoabieta-8,11,13-trien-18-yl]-L-tyrosinate (19) exhibited potent cytotoxic activities against four cancer cell lines with IC50 values of 2.3 (HL60), 7.1 (A549), 3.9 (AZ521), and 8.1 µM (SK-BR-3). Furthermore, all derivatives were shown to possess high selective cytotoxic activities for leukemia cells, since they exhibited only weak cytotoxicities against normal lymphocyte cell line RPMI1788.